Sabitlenmiş Tweet

We surveyed nearly 200 people with type 1 #diabetes about their experiences with #GLP1 therapy — from access pathways to real-world results.
The data reveals both promising outcomes and persistent barriers.
📲 Explore the full findings here:
drive.google.com/file/d/1WD5LCh…

English













